Literature DB >> 4993358

In vitro susceptibility of Brucella to various antibiotics.

W H Hall, R E Manion.   

Abstract

A series of 27 strains of six species of Brucella was tested for susceptibility in vitro to a representative cross section of antibiotics in current use. The activity against each species was plotted, with the cumulative per cent of strains inhibited indicated for each concentration. As a class, the tetracycline antibiotics were the most effective. Erythromycin, gentamicin, streptomycin, and kanamycin, as well as rifampin, were quite active. The penicillin-cephalosporin group, with the exception of ampicillin, was comparatively ineffective, as were the polypeptides and the miscellaneous group of chloramphenicol, lincomycin, cycloserine, and sulfadiazine. Species differences were noticeable, with some strains of B. canis being considerably more resistant to streptomycin and the tetracyclines than B. suis and B. abortus. B. melitensis, B. ovis, and B. neotomae were intermediate in antibiotic susceptibility.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4993358      PMCID: PMC376998          DOI: 10.1128/am.20.4.600-604.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  3 in total

1.  The action of "Penbritin" on Brucella micro-organisms.

Authors:  E AGIUS; J MIFSUD
Journal:  Arch Inst Pasteur Tunis       Date:  1962-03

2.  EXPERIMENTAL STUDIES ON THE ACTION OF STREPTOMYCIN, AUREOMYCIN, AND CHLOROMYCETIN ON BRUCELLA.

Authors:  E M Yow; W W Spink
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

3.  [Contribution on the differentiation within the species Brucella abortus by means of antibiotics].

Authors:  W Fritzsch; W Abadjieff
Journal:  Zentralbl Bakteriol Orig       Date:  1966-12
  3 in total
  16 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Brucellosis.

Authors:  D W Martin; H D Watts; L H Smith
Journal:  West J Med       Date:  1975-03

3.  Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.

Authors:  M C Lecaroz; M J Blanco-Prieto; M A Campanero; H Salman; C Gamazo
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

4.  Efficacy of ciprofloxacin for treatment of Brucella melitensis infections.

Authors:  M B al-Sibai; M A Halim; M M el-Shaker; B A Khan; S M Qadri
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains.

Authors:  Steven D Brown; Maria M Traczewski
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Porins of Brucella species.

Authors:  J T Douglas; E Y Rosenberg; H Nikaido; D R Verstreate; A J Winter
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils.

Authors:  O Rasool; E Freer; E Moreno; C Jarstrand
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  In vitro susceptibility of Brucella melitensis to antibiotics.

Authors:  E Rubinstein; R Lang; B Shasha; B Hagar; L Diamanstein; G Joseph; M Anderson; K Harrison
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

9.  In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.

Authors:  A Gutiérrez Altés; M Díez Enciso; P Peña García; A Campos Bueno
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

10.  Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.

Authors:  J Ariza; J Bosch; F Gudiol; J Liñares; P F Viladrich; R Martín
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.